Medical Card System, Inc. – Trademark Portfolio
Entity Type: 03
Medical Card System, Inc. has 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include MCS and MEDICAL CARD SYSTEM. The portfolio includes 2 registered trademarks. Filings span 3 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 36 (Insurance & Financial). This trademark owner is based in San Juan, PR.
Corporate Affairs Division MCS Plaza
255 Ponce de Leon Avenue
San Juan, PR 00918
Showing of trademarks Trademarks
Trademark Classifications
Medical Card System, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Medical Card System, Inc. have?
Medical Card System, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned.
What trademark classes does Medical Card System, Inc. file in?
Medical Card System, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Medical Card System, Inc.'s most well-known trademarks?
Medical Card System, Inc.'s registered trademark portfolio includes well-known marks such as MCS and MEDICAL CARD SYSTEM. These are among 2 currently registered trademarks in the portfolio.
What is Medical Card System, Inc.'s trademark registration success rate?
Medical Card System, Inc. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.